Episode 9 Title: Understanding Prior Authorization in Healthcare

What has recently intensified scrutiny on prior authorization in healthcare?

The increased scrutiny on prior authorization stems from its growing use by payers, which has heavily burdened physician practices. There is skepticism about the review process due to the industry's failure to reform as promised in 1998. Despite a watered-down consensus statement in 2025, the skepticism remains valid as the industry has largely admitted to not implementing meaningful reforms.

How does the purpose of prior authorization differ from its function in practice?

Prior authorization is described by plans as a utilization management tool, but in practice, it often involves outsourced organizations like pharmacy benefit managers (PBMs) and radiology benefit managers. These entities have faced criticism for profiting from negotiated discounts that don't benefit providers. The system's decision-making process lacks transparency and is influenced by financial incentives rather than science-based criteria.

How has the health plan industry responded to criticism about prior authorization?

The health plan industry has repeatedly promised reforms, issuing detailed consensus statements that many plans have not followed through on. As states begin regulating PBMs and other managers, the burden of prior authorization has expanded to more services, causing frustration for physicians managing these processes.

What administrative burden does prior authorization place on physicians and staff?

Physicians report handling an average of 39 prior authorizations weekly, which contributes to burnout and increased denials over time. It consumes 13 hours of physician and staff time each week, with 40% of physicians employing staff specifically for this task. The process often leads to higher utilization and unnecessary treatments, compounding its inefficiency.

What issues arise from using predictive algorithms and AI in prior authorization?

The use of AI and predictive algorithms in prior authorization raises concerns about the inputs and the scientific robustness of the data used. While these technologies could potentially improve decision-making, the industry's history of inadequate reform casts doubt on their effective implementation.

What does the appeal status reveal about Medicare Advantage prior authorization denials?

In 2023, Medicare Advantage insurers fully or partially denied 6.4% of the requests. Amazingly, only 11.7% of those denials were appealed.  That means of the 46 million reviews, almost 3 million entailed denials and only a little more than 344,000 were appealed. This raises questions about the validity and consistency of the initial denial processes.

How do new CMS rules impact prior authorization processes?

New CMS rules introduce application programming interfaces (APIs) to improve transparency and efficiency. These rules require plans to publicly disclose services subject to prior authorization and establish timelines for decisions and appeals. Compliance with these rules remains to be seen, and states are playing a larger role in regulating these processes.

Is prior authorization moving towards meaningful reform or incremental changes?

While detailed CMS and state regulations indicate some reform, much of it is not voluntarily adopted by the industry. Some plans, like United, have announced reductions in required authorizations, but skepticism remains about the effectiveness of these changes. The ongoing regulation and industry response may lead to improvements, but significant skepticism persists.